1. Home
  2. DTST vs GBIO Comparison

DTST vs GBIO Comparison

Compare DTST & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTST
  • GBIO
  • Stock Information
  • Founded
  • DTST 2001
  • GBIO 2016
  • Country
  • DTST United States
  • GBIO United States
  • Employees
  • DTST N/A
  • GBIO N/A
  • Industry
  • DTST EDP Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DTST Technology
  • GBIO Health Care
  • Exchange
  • DTST Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • DTST 24.0M
  • GBIO 23.2M
  • IPO Year
  • DTST N/A
  • GBIO 2020
  • Fundamental
  • Price
  • DTST $3.82
  • GBIO $0.42
  • Analyst Decision
  • DTST
  • GBIO Strong Buy
  • Analyst Count
  • DTST 0
  • GBIO 4
  • Target Price
  • DTST N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • DTST 33.2K
  • GBIO 571.4K
  • Earning Date
  • DTST 05-14-2025
  • GBIO 05-12-2025
  • Dividend Yield
  • DTST N/A
  • GBIO N/A
  • EPS Growth
  • DTST 40.00
  • GBIO N/A
  • EPS
  • DTST 0.07
  • GBIO N/A
  • Revenue
  • DTST $25,371,303.00
  • GBIO $19,892,000.00
  • Revenue This Year
  • DTST $12.17
  • GBIO N/A
  • Revenue Next Year
  • DTST $9.68
  • GBIO $10.90
  • P/E Ratio
  • DTST $52.86
  • GBIO N/A
  • Revenue Growth
  • DTST 1.65
  • GBIO 236.92
  • 52 Week Low
  • DTST $2.93
  • GBIO $0.32
  • 52 Week High
  • DTST $8.00
  • GBIO $4.34
  • Technical
  • Relative Strength Index (RSI)
  • DTST 57.16
  • GBIO 52.81
  • Support Level
  • DTST $3.34
  • GBIO $0.34
  • Resistance Level
  • DTST $3.78
  • GBIO $0.46
  • Average True Range (ATR)
  • DTST 0.23
  • GBIO 0.05
  • MACD
  • DTST 0.06
  • GBIO 0.02
  • Stochastic Oscillator
  • DTST 98.82
  • GBIO 93.33

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: